Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

AVITA Medical Inc

RCEL ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Small Cap Analyst: BUY

Last Close

$10.50

▲ +5.95%

Market Cap $324.73M · Vol 117.35K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$324.73M

Small Cap

Div Yield

N/A

EPS Growth

+54.31%

YoY

RSI (14)

88.02

Momentum

Beta

1.99

vs Market

52W High

$10.76

2.42% below

52W Low

$3.23

225.08% above

Volume

117.35K

Avg 140.30K

P/B

N/A

Price-to-book

ROE

799.72%

Return on equity

Free Float

98.48%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, AVITA Medical Inc (RCEL) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does RCEL pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+6.60%

+127.77%

+129.26%

+110.00%

YTD

+204.35%

+125.81%

-34.13%

-42.78%

Financials & Valuation

TTM · Annual

Total Revenue	$71.61M
Net Income	$-48,587,000.00
Revenue Growth (YoY)	+17.83%
Gross Margin	83.26%
Operating Margin	-57.43%
Net Profit Margin	-67.85%
ROE	799.72%
ROA · ROIC	-71.38% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.34
P/B	N/A
P/FCF	N/A
EPS Growth	+54.31%
Outstanding Shares	30.93M

Technical Indicators

50-Day SMA	$5.63
200-Day SMA	$4.49
RSI (14)	88.02
Beta	1.99
52-Week High	$10.76
52-Week Low	$3.23

Volume Today	117.35K
Avg Daily Volume (30D)	140.30K
Relative Volume	0.84x
Volatility (10D)	111.60
Volatility (30D)	163.35
Free Float	98.48%

Analyst Consensus

BUY

Current Price $10.50

Mean Target $11.00

52W Low$3.23 52W High$10.76

Current

Target

$3.23 $10.76

Current Analyst target

+4.76% upside potential · 4 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00TD18TF1

ISINUS05380C1027

CountryUnited States of America

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateNov 6, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG +1.02% ONC BeOne Medicines AG +1.18% RVMD Revolution Medicines Inc -0.09% 068270.KS Celltrion Inc -2.27% ABVX Abivax SA +1.53%

Company Profile

AVITA Medical, Inc. is a therapeutic acute wound care company. The Company solutions are designed to optimize wound healing, accelerate patient recovery, and improve clinical and economic outcomes across the continuum of acute wound management. Its technologies address critical healing needs arising from burns, traumatic injuries, and surgical repairs, through a portfolio and complementary products that support wound bed preparation, definitive closure, and recovery. Its portfolio includes RECELL and two complementary wound care products, PermeaDerm and Cohealyx. Its RECELL technology platform is an autologous cell harvesting technology that enables clinicians to create a suspension of a patient's own skin cells, called Spray-On Skin, at the point of care. Its PermeaDerm is a biosynthetic wound matrix that manufactures, markets, and distributes in the United States, under multi-year agreements with Stedical.